study question: What proteins are carried by extracellular vesicles (EVs) released from normal first trimester placentae? summary answer: One thousand five hundred and eighty-five, 1656 and 1476 proteins were characterized in macro-, micro-and nanovesicles, respectively, from first trimester placentae, with all EV fractions being enriched for proteins involved in vesicle transport and inflammation.
Introduction
During human pregnancy, feto-maternal communication is essential to induce the complex series of physiological adaptations that the mother must undergo to accommodate and nourish the growing fetus. These adaptations include the induction of tolerance of the maternal immune system to the fetus/placenta, which is in effect a tissue transplant (allograft), as well as increases in blood volume and cardiac output with an accompanying drop in systemic vascular resistance (Sibai and Frangieh, 1995) . Exactly how this extensive feto-maternal communication occurs is not yet known, but a newly emerging hypothesis proposes that this may be through extracellular vesicles (EVs) which are extruded from the placenta into the maternal blood.
The surface of the human placenta is covered by a single multinucleated cell, the syncytiotrophoblast, which is bathed in maternal blood. In all pregnancies, EVs are extruded from the syncytiotrophoblast into the maternal blood and recently it has been suggested that these vesicles may play an important role in the maternal adaptation to normal pregnancy (Mincheva-Nilsson and Baranov, 2010; Abumaree et al., 2012; Chamley et al., 2014) . The syncytiotrophoblast extrudes an unusually wide range of EVs including multinucleated syncytial nuclear aggregates (SNAs, 20 -100 mm), as well as subcellular microvesicles (,1 mm) and nano-vesicles, including exosomes (,100 nm) (Mincheva-Nilsson and Baranov, 2010; Chamley et al., 2014; Tong and Chamley, 2015) .
Once extruded from the syncytiotrophoblast, EVs are removed from the uterus via the venous drainage into the maternal circulation. The smaller micro-and nano-vesicles will presumably become dispersed to the maternal periphery while it has been observed that the largest placental macro-vesicles (SNAs) are entrapped in the pulmonary capillary beds (Schmorl, 1893) . How placental EVs are cleared from the maternal circulation is not known, but studies have shown that they are rapidly removed from the circulation after removal of the placental source (Reddy et al., 2008) . It is most likely that maternal immune and endothelial cells are responsible for clearing the vesicles and in doing so, these maternal cells are exposed to the wide range of molecules that are contained on or within the vesicles, including regulatory RNAs, DNA and a wide range of proteins (Gupta et al., 2004; Rajakumar et al., 2012; Delorme-Axford et al., 2013; Tong and Chamley, 2015) .
Different-sized EV fractions are likely to carry different cargos, which will affect maternal cells differently. However, to our knowledge, this has not been previously investigated. Therefore, in this study, we used liquid chromatography-coupled tandem mass spectrometry and western blotting to characterize the proteomes of macro-, micro-and nano-vesicles derived from the same first trimester placentae. There are two purposes to this study: (i) to investigate how placental EVs may mediate fetomaternal communication, and (ii) to generate protein lists from which specific markers of placental EVs may be developed to assist in the isolation and purification of placental EVs from the maternal blood, a major hurdle hindering current placental EV research.
Materials and Methods

Human ethics approval
This study was approved by the Auckland Regional Health and Disabilities Ethics Committee. All placentae were obtained from Epsom Day Unit, Greenlane Hospital (Auckland, New Zealand) following elective surgical termination of pregnancies with informed written consent.
Reagents
All cell culture reagents including Advanced Dulbecco's modified eagle medium/Nutrient mixture F-12 (DMEM/F12), penicillin/streptomycin, fetal bovine serum (FBS) and CD45+ magnetic beads were purchased from Invitrogen (Auckland, New Zealand). Throughout the study, the same batch of FBS was used.
Collection of trophoblastic EVs
Trophoblastic EVs were collected from first trimester placentae (8 -12 weeks of gestation) as previously described (Abumaree et al., 2006a) . Briefly, placental explants of around 400 mg were dissected from first trimester placentae and cultured in Netwell TM inserts (Corning, New Zealand) in DMEM/F12 medium supplemented with 2% FBS (v/v) and 100 U/ml penicillin, 100 mg/ml streptomycin. Placental explants were incubated in either 2, 6 or 21% oxygen with 5% CO 2 in N 2 at 378C for 16 h. The culture medium was then aspirated from the culture wells to collect trophoblastic EVs.
Fractionation of trophoblastic vesicles
Trophoblastic EVs of different sizes was separated by sequential centrifugation at 48C at 2000g for 5 min (macro-vesicles), 20 000g for 1 h (microvesicles) and 100 000g for 1 h (nano-vesicles) (Avanti J30I Ultracentrifuge, JA 30.50 Ti fixed angle rotor, Beckman Coulter, New Zealand). Contaminating red blood cells were removed from the macro-vesicle fraction by hypotonic lysis in ultrapure water (EMD Millipore, New Zealand) and contaminating leucocytes were depleted using anti-CD45 magnetic beads according to the manufacturer's instructions.
Placental weights
Pellets of macro-, micro-and nano-vesicles were weighed after removal of all traces of culture medium. The weight of the individual tubes, as well as the weight from centrifuging the equivalent volume of DMEM/F12 medium was subtracted prior to normalization to placental explant weight.
Electron microscopy
Micro-and nano-vesicles were resuspended in ultrapure water and coated onto Formvar-coated copper mesh grids (ProSciTech, Australia). Grids were stained with 2% uranyl acetate (w/v) and viewed under a Tecnai TM G 2 Spirit Twin transmission electron microscope. Micrographs were taken by the attached SIS Morada Camera and processed using the SIS iTEM software (Soft Imaging Systems, Germany).
Dynamic light scattering
Micro-and nano-vesicles from 1 g of placental tissue were resuspended in 0.2 mm filtered phosphate-buffered saline (PBS) and analysed on a Zetasizer NanoZS (Malvern Instruments, UK), with refractivity at 1.45 and absorption at 0.01. Data were analysed by Malvern software 7.04 (Malvern Instruments).
Nanoparticle tracking analysis
Micro-and nano-vesicles from 0.5 g of placental tissue were resuspended in PBS to reach measurable concentrations of 2 -10 × 10 8 vesicles/ml and analysed on an NS300 Nanosight instrument equipped with a 405 nm laser and a sCMOS camera (Nanosight, UK). All automatic settings were applied with viscosity setting at 0.95 cP and temperature at 258C. A single measurement consists of three 30-s videos and each sample was measured five times at camera level 10. The detection threshold was set at 10, and data acquisition and processing was performed using the NTA3.0 software (Nanosight). Only recordings with over 1000 valid tracks/vesicles were included in the analysis.
Liquid chromatograph-coupled tandem mass spectrometry
Macro-, micro-and nano-vesicles were prepared from three placentae (gestation ¼ 11 weeks + 2 days) as described above, at 21% oxygen culture conditions. Total protein from each fraction were extracted using radioimmunoprecipitation assay buffer [50 mM Tris, 150 mM NaCl, 1% sodium deoxycholate, 0.1% sodium dodecyl sulphate (SDS), 1% Nonidet P40 substitute, 1 mM phenylmethylsulfonyl fluoride, pH7.4] supplemented with protease inhibitor (Roche, USA). Typically, 50, 75 and 50 mg of protein is derived from 1 g of placental tissue for each macro-, micro-and nano-vesicle preparation, and 10 mg of total protein was resolved on 11% SDS-polyacrylamide gel electrophoresis (PAGE) gels under reducing conditions. Proteins were in-gel reduced, alkylated and digested with trypsin (DigestPro Msi, Germany) as previously described (Shevchenko et al., 1996) . Peptide fragments were reconstituted in 5% acetonitrile and 0.2% formic acid, and separated using the Ultimate 3000 nano-flow uHPLC-System (Dionex Co, USA) inline coupled to the nanospray source of a LTQ Orbitrap XL mass spectrometer (Thermo Scientific, USA). Full MS scans were performed in the Orbitrap mass analyser in a mass range between m/z 400 and 2000 at a resolution of 60 000. The strongest six signals per scan were selected for collision-induced dissociation (CID)-MS/MS in the LTQ ion trap at normalized collision energy of 35%. To improve protein identification, each fraction was subjected to a second analysis using a 5-25% acetonitrile gradient, and eight data-dependent CID scans per scan set.
Raw data were processed using the Proteome Discoverer Software (version 1.4; Thermo Scientific) to generate peak lists that were searched against the Human Reference amino acid sequence database (ftp://ftp .ncbi.nlm.nih.gov/refseq, June 2013) using SequestHT (Thermo Scientific), MS Amanda (version 1.4.4, http://ms.imp.ac.at/?goto=msamanda) and Mascot (version 2.4, http://www.matrixscience.com). Peptide validation and false discovery rate (FDR) calculations were performed using the Percolator algorithm (Kall et al., 2007) . In addition to a FDR threshold of 1% (q ¼ 0.01), peptide hits were filtered using conservative scoring thresholds: MS Amanda (.100), Mascot (.25) and SequestHT scores of 2.4 -3.6, depending on charge state. Only proteins that were identified by two or more unique peptides that passed the peptide filters were accepted.
Protein lists were uploaded to Venny (Oliveros, 2007) for qualitative comparison of the detected protein profiles. Protein lists were further analysed using Gene Ontology pathway analysis on DAVID Version 6.7 Huang da et al., 2009) to determine pathways and functions of interest.
Western blotting
Total protein from macro-, micro-and nano-vesicles was extracted and resolved on 11% polyacrylamide SDS -PAGE gels as described. Protein lysates were transferred to Hybond TM -C extra nitrocellulose membranes (Amersham Biosciences, UK). Successful protein transfer was confirmed with Ponceau S staining. Non-specific binding of subsequent antibodies was prevented by incubation of membranes with blocking solution (5% non-fat milk powder in PBS-Tween) for 1 h at ambient temperature.
Membranes were incubated with primary antibodies (Supplementary data, Table SI ) diluted in blocking solution overnight at 48C with mild agitation. After washing, membranes were incubated with horseradish peroxidase (HRP)-conjugated anti-rabbit, anti-mouse or anti-goat IgG antibody (Jackson ImmunoResearch, USA). The presence of target proteins were detected using Amersham TM ECL TM Prime detection reagent and visualized on Image Quant LAS3000 (GE Healthcare, UK). Images were annotated using Adobe w Photoshop w Elements 5.0. The molecular weights of protein bands were measured from the Precision Plus protein TM All Blue standard (Bio-rad, USA). Protein abundance was semi-quantified by densitometry relative to b-actin using the Kodac Digital Science 1D image analyser (Kodac, Japan).
Statistical analysis
The Shapiro -Wilk normality test was performed on GraphPad Prism 6.01 Software (GraphPad Software Inc., USA) showing that the vesicle weight data were not normally distributed. Thus, the non-parametric KruskalWallis test was used with Dunn's multiple comparisons testing to assess statistical difference. A P-value ,0.05 was considered statistically significant. The statistical significance of protein enrichment was calculated on DAVID by the modified Fisher's exact test. An adjusted P-value ,0.05 was considered statistically significant (Huang da et al., 2009) .
Results
Quantification of vesicle production by first trimester placentae
To quantify the amount of vesicles that were produced from first trimester placentae, vesicles were separated into different size fractions: macro-, micro-and nano-vesicles (n ¼ 56 -89 placentae) by sequential centrifugation. The wet weight (median +25/75 percentiles) of macro-, micro-and nano-vesicles produced from each gram of placental explant was significantly different at 4 (2.8 -8.1) mg, 24 (12.1-46.0) mg and 52 (26.4-82.1) mg per gram of placental explant, respectively (P , 0.0002, Fig. 1A ).
To determine if the amount of vesicles produced was related to the gestation of the placenta, the weights of each vesicle pellet were grouped by gestational week (Weeks 7-12). Gestation did not affect the amount of macro-, micro-or nano-vesicles produced from 7 to 12 weeks ( Fig. 1B -D ).
Physical characterization of placental EVs
Placental macro-vesicles were visualized by light microscopy from five placentae ( Fig. 2B ) and micro-and nano-vesicles from three placentae were visualized by transmission electron microscopy ( Fig. 2C and D) . The morphologies of the vesicles were typical of previous reports (Hedlund et al., 2009; Donker et al., 2012; Kshirsagar et al., 2012) . The average diameter of the micro-vesicle population was 290 + 72 nm (n ¼ 11) by dynamic light scattering (DLS) and 160 + 18 nm (n ¼ 15) by nanoparticle tracking analysis (NTA). The average diameter of nano-vesicles was 130 + 20 nm (n ¼ 11) by DLS and 120 + 10 nm (n ¼ 15) by NTA.
Confirmation of the trophoblastic origin of the derived vesicles
To confirm that the vesicles were derived from trophoblasts, lysates of macro-, micro-and nano-vesicles from five placentae were probed for markers of trophoblasts [cytokeratin and placental growth factor (PLGF)], stromal cells (vimentin), leucocytes (CD45) and red blood cells (glycophorin A). A lysate from a placental explant was used as a control and was positive for all five markers. Cytokeratin and PLGF, but not vimentin, were present in all three fractions of vesicles (Fig. 3A -C ). There were traces of CD45 in all fractions of vesicles, but these were strongest in macro-vesicles (Fig. 3D) . Glycophorin A was detected only in the macro-vesicle fraction (Fig. 3E) .
Effect of oxygen concentration in the culture environment on the production of micro-and nano-vesicles from first trimester placental explants
In order to investigate whether the level of oxygen in the culture environment affected the number of micro-and nano-vesicles produced from the placenta, explants from 10 placentae (5 less than 10 weeks of gestation, and 5 over 10 weeks of gestation) were cultured in 2, 6 or 21% oxygen. Oxygen concentration did not affect the number of vesicles produced from the explants, the amount of protein carried by the vesicles (Fig. 4A and B) or the mean and modal sizes of the micro-and nanovesicles produced ( Fig. 4C and D) regardless of the gestational age of the placenta (Supplementary data, Fig. S1 ).
Characterization of the proteomes of trophoblastic macro-, micro-and nano-vesicles
Total protein lysates from macro-, micro-and nano-vesicles from three gestation-matched first trimester placentae were analysed by tandem mass spectrometry. A total of 1585 proteins were identified in macro-vesicles, 1656 proteins were identified in micro-vesicles and 1476 proteins were identified in nano-vesicles (Supplementary data, Table SII ). This mass spectrometry data have been deposited to the ProteomeXchange Consortium (http://proteomecentral.proteomexchange.org) via the PRIDE partner repository with the dataset identifier PXD003003 (Vizcaino et al., 2013) . Of these proteins, 1125 proteins were shared between all three fractions of vesicles while 223 proteins were unique to macro-vesicles, 51 proteins were unique to micro-vesicles and 38 proteins were unique to nano-vesicles (Fig. 5) . Table I shows the top pathways enriched in each fraction of trophoblastic vesicles following pathway analysis on Gene Ontology. Of interest, proteins involved in transport or vesicle trafficking and pro-inflammatory responses were abundant in all fractions of trophoblastic vesicles (P , 0.01, Table I ).
Validation of protein expression
Western blotting was used to confirm the expression of proteins identified in the mass spectrometry analysis of trophoblastic EVs. As proteins Proteome of human placental extracellular vesicles involved in vesicle trafficking and pro-inflammatory responses were highly abundant in all EV fractions (Table I) , we focused on further investigating proteins involved in: (i) vesicle-target cell interactions, (ii) complement regulation and (iii) minor histocompatibility antigens (mHAgs), for verification by western blotting. These three pathways are relevant to feto-maternal communication and successful maternal adaptation to pregnancy.
Proteins involved in vesicle-cell interactions
Western blots of vesicles from 17 placentae demonstrated that annexin V was present in all fractions of trophoblastic vesicles (Fig. 6A) . Densitometric comparison of the level of annexin V, normalized to b-actin, showed that levels are significantly increased in micro-vesicles, compared with both macro-vesicles (P ¼ 0.0006) and nano-vesicles (P ¼ 0.0026, Fig. 6A ). Similarly, calreticulin (n ¼ 15 placentae) is present in all fractions of trophoblastic vesicles, with significantly higher levels in micro-vesicles compared with macro-vesicles (P ¼ 0.0219, Fig. 6B ). CD31 and CD47 (n ¼ 12 placentae) were present at similar levels in macro-and microvesicles, but the levels of both proteins were significantly reduced in nano-vesicles ( Fig. 6C and D , P , 0.01).
Proteins involved in complement regulation
Complement component C3 was present at similar levels in all fractions of trophoblastic vesicles derived from 10 first trimester placentae (Fig. 7A) . The three complement regulatory proteins, membrane cofactor protein (MCP; CD46), decay-accelerating factor (DAF; CD55) and protectin (CD59), were also detected in all fractions of trophoblastic vesicles (Fig. 7) . Semi-quantitative analysis demonstrated that MCP and protectin were present at similar levels in all three fractions of trophoblastic vesicles from first trimester placentae (n ¼ 8-15, Fig. 7B  and D) . In contrast, relative to b-actin levels, DAF was most abundant in micro-vesicles, with significantly lower levels in macro-vesicles (Fig. 7C , n ¼ 27 placentae, P , 0.0079) and minimal expression in nanovesicles (P , 0.0001). 
Minor histocompatibility antigens
The presence of two Y-linked mHAgs, ribosomal protein S4 (RPS4) and ATP-dependent RNA helicase (DDX3), was detected by western blotting in all fractions of trophoblastic vesicles from six first trimester placentae. The level of RPS4, relative b-actin levels, was significantly increased in macro-vesicles, compared with micro-vesicles (P , 0.0027, Fig. 8A ), however, levels of DDX3 were not significantly different between fractions (Fig. 8B) .
Discussion
Trophoblastic EVs are extruded from the syncytiotrophoblast in vast quantities during normal pregnancies and this number is significantly increased in pathological pregnancies (Attwood and Park, 1961; Goswami et al., 2006; Chen et al., 2012) . Once in the maternal blood, these EVs have the ability to communicate with and regulate maternal cells via their protein and nucleic acid cargos (reviewed in Tong and Chamley, 2015) . The current placental literature has focused on the effects of EVs on immune cells Abumaree et al., 2012; Holder et al., 2012) , but the effects of EVs on other target/recipient cell types are also increasingly being investigated (Delorme-Axford et al., 2013; Shen et al., 2014) . This study used liquid chromatographycoupled tandem mass spectrometry and western blotting to interrogate the protein cargo of macro-, micro-and nano-vesicles derived from the same first trimester placenta.
This study used an ex vivo placental explant culture method to isolate trophoblastic EVs for proteomic analysis. The method used to produce vesicles can significantly alter the effects that the vesicles have on effector cells, suggesting changes in the vesicles' cargo (Gupta et al., 2005a,b) The top four main pathways that are enriched in these vesicle fractions are shown. % represents the percentage of proteins (of the total number of proteins detected in the EV fraction) that are involved in the pathway investigated. P-values were calculated on DAVID using a modified Fisher's exact test Huang da et al., 2009 ).
Vesicles derived from placental perfusion and explant cultures are thought to mimic the physiological situation more closely than mechanical disruption (Gupta et al., 2005a,b) . Since it is not possible to perfuse early gestation placentae, we used our widely published placental explant culture model to obtain macro-, micro-and nano-vesicles from first trimester placentae. We have previously used this explant culture model to characterize macro-vesicles (Abumaree et al., 2006b) but have not yet examined micro-or nano-vesicles produced from these explants. Therefore, in this study, we examined the morphological features of the three fractions of vesicles using a combination of microscopy, DLS and NTA to confirm that the vesicles extruded from the explants were similar to those that have been previously reported (Dragovic et al., 2011; Webber and Clayton, 2013) . We also used western blotting to confirm that these vesicles are primarily of trophoblastic origin since they contain abundant cytokeratin and PLGF but no vimentin. The vesicle lysates did contain trace amounts of CD45, suggesting minor contamination from leucocyte-derived vesicles, most likely of maternal origin. Macro-vesicles were also positive for glycophorin A, suggesting some contamination from red blood cells in the macro-vesicle fraction but not in micro-or nano-vesicles. These quality control measures suggest that the contamination from non-trophoblast sources was very minor and it is likely that the vast majority of identified proteins in this study came from the relevant placental vesicles.
To approximate the amount of EVs produced by first trimester placentae, vesicle pellets were weighed relative to the wet weight of the starting placental explant. As this method is rather imprecise, a large number of samples (56 -89 placentae) were studied. We observed that during normal pregnancy, the amount/weight of nano-vesicles shed is more than that of micro-vesicles. As nano-vesicles/exosomes are generally considered to be anti-inflammatory while micro-vesicles are pro-inflammatory, it would be interesting to investigate in the future whether the ratio of micro-vesicle:nano-vesicle production is altered in pro-inflammatory obstetric complications, such as pre-eclampsia. Figure 6 Western blot quantification of 'eat me' and 'don't eat me' signals on trophoblastic vesicles. Levels of Annexin V relative to b-actin were variable in macro-, micro-and nano-trophoblastic vesicles derived from 17 placentae (A). Calreticulin was detected at significantly higher levels in micro-vesicles, compared with macro-vesicles derived from 15 placentae (B). CD31 (C) and CD47 (D) were detected predominately in macro-and micro-vesicles, with significantly lower levels in nano-vesicles (from 12 placentae).
We did not see any obvious trend for altered production rates of placental EVs with increasing gestational age during the first trimester. In the main part of this study, we cultured the placental explants in 21% oxygen. While it is known that the human placenta develops in low oxygen conditions in the first 10 weeks of gestation with a progressive increase in oxygen as the trophoblast plugs in the spiral arteries break down from 10 to 13 weeks (Jauniaux et al., 1999; James et al., 2006) , we have previously shown that the amount and nature of macro-vesicles produced from human first trimester placentae was not affected by oxygen concentration (Chen et al., 2011) . Here, we have confirmed that the level of oxygen in which placental explants were cultured (2, 6 or 21%) did not significantly affect the (i) number, (ii) size or (iii) total protein content of micro-or nano-vesicles produced from first trimester placentae regardless of their gestational age (Fig. 4 and Supplementary  data, Fig. 1 ). Whether the presence or abundance of individual proteins in vesicles would change with altered oxygen concentrations requires further investigation.
While trophoblastic EVs are primarily derived from the syncytiotrophoblast, the exact mechanisms by which these vesicles are produced are not clear. It is likely that different biological processes are responsible for the production of the different types of vesicles (Mincheva-Nilsson and Baranov, 2010) . Therefore, we reason that macro-, micro-, and nano-vesicles would have different protein cargos even though they are derived from the same cell. To our knowledge, this is the first time proteomics has been performed on macro-, micro-and nano-vesicles derived from the same normal first trimester placenta, and thus this study adds to the information produced by other proteomic studies of vesicles derived from normal term and pathological placentae (Guller et al., 2011; Baig et al., 2014) . Early gestation placentae were used specifically in this study because many changes that occur in the maternal immune and cardiovascular systems during pregnancy are established in the first trimester and we believe that these EVs may play an important role to support a healthy pregnancy. Nevertheless, there were many proteins that were found in other studies which were also present in our proteomic investigation, including annexins, histones and heat shock proteins which suggest that they may play an important role throughout pregnancy (Baig et al., 2014) . During the preparation of this manuscript, a meta-analysis of the then six available placental-derived EV proteomic datasets was published showing that only three proteins were common to all of the six published datasets: albumin, fibronectin-1 and plasminogen activator inhibitor-1 (Familari et al., 2015) . All three of these proteins are also present in each of our three EV fractions.
Proteomic analysis revealed that pathways involving protein localization, intracellular transport and vesicle-mediated transport were strongly enriched in all vesicle fractions. This may reflect packaging of cellular contents into the various vesicle fractions before they were released from the placenta. As anticipated, proteins involved in inflammatory responses were also highly abundant in all vesicle fractions. Interestingly, there were 83 proteins detected in nano-vesicles which are involved in the regulation of cellular proliferation, which were not found in either macro-or micro-vesicles (Table I ). This clearly demonstrates that different vesicle fractions carry distinct protein cargos and suggests that different vesicle fractions are likely to have distinct effects on the maternal cells that they interact with.
From the proteomic pathway analysis, we focused on two enriched pathways for downstream investigation and validation by western blotting analysis: proteins involved in vesicle transport/interactions and inflammation, as these two processes may be relevant to feto-maternal communication and maternal adaptation to normal pregnancy. We investigated these two processes by examining the presence of proteins important for vesicle-target cell interaction, complement regulation and the presence of mHAgs.
Firstly, we focused on proteins that might be involved in mediating interactions between the vesicles and maternal cells, so-called 'eat me' and 'don't eat me' signals, since we have previously shown that macrovesicles must be phagocytosed by maternal cells to affect maternal cell function (Chen et al., 2006) . We confirmed the presence of 'eat me' signals, annexin V and calreticulin, in all fractions of trophoblastic vesicles. Annexin V and calreticulin have previously been detected by our group in macro-vesicles (Pantham et al., 2015) . The level of annexin V correlates with the level of exposed phosphatidylserine on the outer leaflet of the plasma membrane and it is well established that phosphatidylserine exposure stimulates rapid clearance of apoptotic cells Henson et al., 2001; Schlegel and Williamson, 2001) . Calreticulin works synergistically with phosphatidylserine during apoptosis (Gardai et al., 2005; Clarke and Smyth, 2007) . Therefore, the presence of both calreticulin and annexin V/phosphatidylserine on all fractions of trophoblastic vesicles suggests that phagocytosis contribute to the clearance of trophoblastic vesicles by maternal cells.
'Don't eat me' signals may also play an important role in determining whether maternal cells can internalize trophoblastic vesicles. Gardai and colleagues have shown that CD47 activity is crucial for preventing phagocytosis of viable calreticulin-expressing cells (2005) . The expression of CD47 also prevents phagocytosis of red blood cells by splenic macrophages (Oldenborg et al., 2000) . Another 'don't eat me' signal, CD31, has also been shown to mediate the detachment of live leucocytes from macrophages (Brown et al., 2002) . In this study, we showed that the levels of CD47 and CD31 were significantly lower in nano-vesicles compared with other vesicle fractions, suggesting that the mechanisms involved in the clearance of nano-vesicles from the maternal blood may be different to that of the larger vesicles. Studies are currently underway to investigate the rate of clearance of the different vesicle fractions in vivo.
Secondly, we examined the relative expression levels of complement C3 and complement control proteins on trophoblastic EVs. The complement cascade is an evolutionarily conserved effector system that mediates immune responses against foreign antigens (Holmes and Simpson, 1992; Vanderpuye et al., 1992) . In order to avoid complement-mediated damage, the human syncytiotrophoblast is replete with three regulatory molecules, MCP (CD46), DAF (CD55) and protectin (CD59), that prevent complement activation at the materno-fetal interface (Lokki et al., 2014) . Due to the activities of these three regulatory molecules, complement activation, as indicated by deposition of complement C3, does not usually occur in normal placentae or even in pregnancies complicated by antiphospholipid antibodies . However, we did identify C3 in all three fractions of trophoblastic EVs, suggesting that a functional complement system may be present on these vesicles. While all three complement inhibitors were also present in all fractions of vesicles, the level of DAF was significantly higher in micro-vesicles compared with macro-vesicles, and was Figure 8 Western blot verification of the presence of minor histocompatibility antigens in trophoblastic vesicles. RPS4 was present in all fractions of placental vesicles from six first trimester placentae, however, levels are significantly higher in macro-vesicles than in micro-vesicles (A). ATP-dependent RNA helicase (DDX3) was present at similar levels in macro-, micro-and nano-vesicles derived from six first trimester placentae (B). minimal in nano-vesicles. DAF is a phosphatidylinositol (PI)-anchored protein that has previously been localized to the brush border of the human syncytiotrophoblast (Davitz, 1987; Ferguson and Williams, 1988) . In the future, it would be interesting to investigate whether such proteins are passively packaged into EVs via membrane blebbing, or whether the PI-anchorage allows for specific lateral mobility to target DAF into micro-vesicles.
Interestingly, it has recently been shown that both DAF and MCP regulate T cell function independent of their complement regulatory roles (Clarke and Tenner, 2014) . Therefore, the presence of these proteins in trophoblastic EVs may serve a dual function to prevent complement activation while the EVs are free-floating in the maternal circulation, and also to regulate the function of maternal T cells that might otherwise produce adverse immune responses to paternally derived antigens expressed by the placenta. Previous work has shown that placental EVs can prevent T cell activation (Sabapatha et al., 2006; Taylor et al., 2006) .
Paternally derived antigens expressed by the placenta include mHAgs and this was the final set of proteins investigated in this study. The fetus and its placenta are in effect a tissue transplant. Therefore, to protect the fetus from maternal immune recognition, the syncytiotrophoblast does not express any class I major histocompatibility complex (MHC) molecules. However, mHAg incompatibility have been shown to mediate renal and other transplant rejection in MHC-matched donor-recipient pairs (Goulmy et al., 1996) , as well as recurrent miscarriage and recurrent placental abruptions (Christiansen et al., 2011) . Further, maternal immune cells reactive against fetal mHAgs have been reported in mothers post-delivery (James et al., 2003; Piper et al., 2007) , suggesting that these mHAgs may mediate immune responses during pregnancy. We have previously shown that the syncytiotrophoblast, as well as placental macro-vesicles, expressed at least one Y-linked mHAg, DDX3 (Holland et al., 2012) . Our results here confirm the expression of DDX3 in macro-vesicles and also show that both DDX3 and a second mHAg, RPS4 are expressed in all fractions of trophoblastic EVs. Since there is evidence that trophoblastic EVs from normal pregnancies are anti-inflammatory and can induce maternal immune tolerance (Abumaree et al., 2006a (Abumaree et al., , 2012 , mHAgs on trophoblastic EVs may be an important mechanism by which the maternal immune system is able to recognize and tolerate the fetal allograft during a healthy pregnancy or alternatively, to generate a destructive immune response in cases of recurrent miscarriage or recurrent placental abruption. Future functional studies are required to investigate these possibilities.
A caveat in the interpretation of this study is the use of b-actin to normalize the protein loading between the three different fractions of placental EVs. b-actin was chosen as a normalization control as it is commonly used as a loading control in other placental EV studies (Abrahams et al., 2004; Tannetta et al., 2013) . However, further work is required to confirm that this protein is present at similar levels in the different vesicles fractions.
In summary, we have characterized the proteomes of macro-, microand nano-vesicles derived from early gestation normal human placentae. While the majority of the proteins in these three EV fractions are shared, indicating their common origin from the syncytiotrophoblast, many proteins were uniquely identified in only one or two of the vesicle fractions and were expressed at different levels. This indicates that trophoblastic macro-, micro-and nano-vesicles are each likely to be produced by different mechanisms and have distinct effects on the maternal cells with which they interact, each mediating communication between the fetus and its mother, a crucial process for both healthy and pathological pregnancies.
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